Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metazym in late infantile metachromatic leukodystrophy
NCT00633139Phase 2Completed
- Sponsor
- Takeda
- Start
- Jan 2007
- Primary completion
- Nov 2008
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of cebsulfase alfa in late-infantile metachromatic leukodystrophy (MLD), sponsored by Takeda. Started Jan 2007; status: completed.
02
Drugs
cebsulfase alfa
03
Conditions
late-infantile metachromatic leukodystrophy (MLD)
Beyond the preview
Go deeper on NCT00633139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633139.